Canine atopic dermatitis

Advice for veterinary professionals

Please select your country
Search this site
Novartis Animal Health

Home > Atopica > Treatment comparison


Treatment comparison

Treatment comparison

Evidence

See the treatment comparison (below) for an overview of how Atopica compares with other treatments for canine atopic dermatitis and view the clinical case studies to see just how effective Atopica is.

Prescribe Atopica with confidence

Confidence in efficacy

  1. Atopica is proven to significantly relieve pruritus and reduce skin lesions1,2
    • Atopica is rated more effective than steroids1
    • 97% of pet owners say Atopica improved their dog's quality of life3
  2. Confidence in a good safety profile
    • Side effects of Atopica are generally mild, transient and reversible4
    • No increased susceptibility to bacterial infections with Atopica4
  3. Confidence of owners
    • Over 98% of pet owners would recommend Atopica to a friend3
  4. Confidence in lasting comfort
    • Many dogs gain comfort with a tapered dose of Atopica - every other day or twice weekly1-5
Therapy Reason for use5 Strength of recommendation*5 Customer satisfaction6
Atopica Reduce pruritus and skin lesions A 85%
Corticosteroids Reduce pruritus and skin lesions A 56%
Antihistamines Reduce pruritus and skin lesions D 49%
Essential fatty acids Improve skin & coat care B 36%
Immunotherapy Prevent recurrence of signs A 42%

* Rating scale of A-F where A refers to the highest category of evidence of safety and efficacy and F refers to the lowest category of evidence of safety and efficacy.

References:

  1. Steffan J et al. Vet Dermatol 2003;14:11-22. 
  2. Steffan J et al. JAVMA 2005;226:1855-1863. 
  3. Control Zone Pet Owner Survey, USA 2006. 
  4. Steffan J et al. Vet Dermatol 2006;17:13-16. 
  5. Olivry T et al. Vet Dermatol (2010) 21, p233-248.
  6. Atopica Customer Satisfaction Study (2008).
Do you want to receive regular updates?
Terms of use | Privacy policy | Contact us | Sitemap | © 2012 Novartis Animal Health Inc., Basel | 2010000 - 67